Skip to main content
Earnings Labs
Zevra Therapeutics, Inc. logo

Zevra Therapeutics, Inc. (ZVRA)

NASDAQ·Healthcare·Biotechnology

$10.43

+3.83%

Mkt Cap $562.18M

Analyst Ratings

Buy

11

Hold

0

Sell

0

Price Target (19 analysts)

$25.75

Range $20.00$35.00

Implied Upside

+146.9%

Consensus $25.75 vs current $10.43